Emergency Contraceptive Ella Needs Minimal Risk Management, Panel Says

In giving its unanimous backing to the safety and efficacy of HRA Pharma's emergency contraceptive Ella (ulipristal), FDA's Reproductive Health Drugs Advisory Committee wanted to make sure that pregnancy tests and other risk management measures that members deemed unnecessary would not get in the way of patients using the product